Arrivo BioVentures Funding & Investors

Arrivo BioVentures LLC operates as a biopharmaceutical company. The Company develops and manufactures clinical drugs. Arrivo BioVentures serves the healthcare sector in the United States.

Total Amount Raised: $94,250,000

Arrivo BioVentures Funding Rounds

Series B
$45,250,000
Nov 28, 2023
Series B Investors
Rex Health Ventures
Orlando Health Ventures
Solas BioVentures
Series A
$49,000,000
May 24, 2016
Series A Investors
Rex Health Ventures
Jazz Pharmaceuticals
Solas BioVentures

Funding info provided by Diffbot.